Matches in Nanopublications for { ?s ?p "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP624210.RABuST5h-mBOsQ-m0_SRK0C_LzwbXcqhbI6AUmKZiVGG0130_assertion description "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624210.RABuST5h-mBOsQ-m0_SRK0C_LzwbXcqhbI6AUmKZiVGG0130_provenance.
- assertion description "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_assertion description "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403827.RATzIM0AaXo0tv8IgA7EWZWbhhWNL2OpBJoe6SJCzz_so130_provenance.
- NP771745.RAx9iPMAMjKlsCrB04vMMmBGMEY4WcZwe0E3f9-mS8qog130_assertion description "[We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771745.RAx9iPMAMjKlsCrB04vMMmBGMEY4WcZwe0E3f9-mS8qog130_provenance.